CLOV vs TRU · rev $1.37B vs P/E 19, rev $4.58B
Clover Health Investments Corp (CLOV) versus TransUnion (TRU) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
TransUnion (TRU) is a financial data & stock exchanges company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TRU revenue for 2025-12-31 was $4.58B. Net income was $455.4M. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. TRU currently screens at market cap $13.41B and trailing P/E 19.3.
CLOV currently screens at market cap $1.55B. TRU currently screens at market cap $13.41B and trailing P/E 19.3.
Not investment advice. Open the CLOV and TRU stock pages for the full models.
Not investment advice.